We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

New Sensitive Bioluminescent Caspase-Glo® 2 and 6 Assays: Using Inhibitors to Achieve...

New Sensitive Bioluminescent Caspase-Glo® 2 and 6 Assays: Using Inhibitors to Achieve Specificity in Cells
  • Print
  • Email
  • Download PDF

Abstract

Our new, extremely sensitive, homogeneous luminescent caspase-2 and -6 apoptosis assays provide unique tools for defining the function of these elusive caspases. An understanding of cross-reactivity between caspases, their substrates, and the various peptide inhibitors is critical for interpreting results from apoptosis studies. Here we provide details on using the Caspase-Glo® 2 Assay  in cells.

Cell Notes 19, 8–13.

Martha O'Brien, Cassandra Broulette, Michael Scurria, Laurent Bernad and William Daily

Promega Corporation and Promega Biosciences

Publication Date: 2007

Download Article (316 KB)

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.